Rhabdomyolysis following Interferon-beta Treatment in a Patient with Multiple Sclerosis - a Case Report

Conclusion Clinicians should be aware of the possibility of rhabdomyolysis occurring during Interferon-beta-1-alpha therapy. In cases where patients complain of severe myalgia, and in particular if weakness is reported, creatine kinase activity should be measured to prevent irreversible rhabdomyolysis during Interferon-beta-1-alpha therapy in patients with multiple sclerosis.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research